With recent attention focused on hospital prices, WellPoint and its peers have been enjoying a nice break from their long-running status as Public Enemy No. 1 in the nation’s health care debate. They shouldn’t expect it to last.
A new recommendation from the Medicare Payment Advisory Commission, if enacted, would likely end one of the ways Indianapolis-area hospitals have generated healthy revenue from their recent spree of physician acquisitions.
To get control of health care spending, prominent health policy wonks are calling for new rules requiring hospitals and insurers to raise the ‘veil of secrecy’ they have thrown over their prices for decades.
In the first post on my new blog, The Dose, I explain why the recently released Medicare charge data are meaningless for everyone but uninsured patients.
The study results, which will be released Monday afternoon, are part of Indianapolis-based Lilly’s campaign to get Medicare to pay for use of its brain imaging agent Amyvid.
Rather than raising prices on private health insurers to make up for inadequate payments from the government, hospitals across the country have been raising prices just because they can, according to a new study.
Shares of Indianapolis-based WellPoint rose along with those of other medical insurers Tuesday morning after the U.S. government reversed a decision to cut a key Medicare payment rate, offering them an increase instead.
The sequestration plan kicking in Friday will chop Medicare payments to hospitals, doctors and nursing homes by 2 percent, beginning April 1. One study estimates that the cuts could result in 10,000-plus job losses in Indiana alone.
The Centers for Medicare and Medicaid Services agreed to a waiver that would allow the state to continue the program unchanged for a year.
Carmel-based ABC Homecare LLC closed last week after state and federal authorities cut off its access to Medicare and Medicaid reimbursement due to deficiencies cited by the Indiana State Department of Health.
WellPoint Inc.’s National Government Services unit will add more than 100 jobs in Indianapolis beginning late this year or early next after the health insurance giant won a new contract with the federal Medicare program.
WellPoint Inc.’s $4.9 billion offer for Virginia-based Amerigroup Inc. apparently wasn’t the only—or even the most lucrative—offer for the Medicaid managed care company. But it was the deal surest to come to fruition before a key deadline for a big payout for Goldman Sachs & Co., according to a shareholder lawsuit filed Aug. 16 against the Amerigroup board of directors.
A little extra Medicare money will flow to suburban hospitals in the Indianapolis area, based on recent patient satisfaction scores. But hospitals in the core of Indianapolis—and hospitals that do significant amounts of teaching medical students—may take a hit.
Investors and analysts like the fact that WellPoint is playing more aggressively in government-sponsored health plans, such as Medicaid and Medicare, which are projected to be the key sectors for growth for the next several years.
While upholding President Obama’s health care law, the U.S. Supreme Court may have created a way out for states that do not want to expand their Medicaid programs. Whether Indiana decides to opt out remains to be seen.
The Supreme Court is expected to rule on the Affordable Care Act by the end of June. Here’s a roundup of how health care businesses would be affected under four different scenarios.